Covered recipient · General Payments record
ANITA PATIBANDLA
Allopathic & Osteopathic Physicians Obstetrics & Gynecology
General Payments · PY2018–2024
$9,768.68
- Reported across 49 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $252.72 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Sage Therapeutics, Inc. | $70.03 | 2 |
| Organon LLC | $64.64 | 7 |
| Astellas Pharma US Inc | $56.25 | 3 |
| OptumHealth Care Solutions, LLC | $31.65 | 2 |
| Exeltis, USA Inc. | $17.00 | 1 |
| PFIZER INC. | $13.15 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Astellas Pharma US Inc | $21.67 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139325762 | CMS |
| Astellas Pharma US Inc | $13.33 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139336558 | CMS |
| Astellas Pharma US Inc | $21.25 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139408945 | CMS |
| Exeltis, USA Inc. | $17.00 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150001676 | CMS |
| OptumHealth Care Solutions, LLC | $16.40 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153140242 | CMS |
| OptumHealth Care Solutions, LLC | $15.25 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153140244 | CMS |
| Organon Llc | $0.94 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136193598 | CMS |
| Organon Llc | $13.08 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136193600 | CMS |
| Organon Llc | $15.50 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136193602 | CMS |
| Organon Llc | $1.10 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136193594 | CMS |
| Organon Llc | $17.67 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136193596 | CMS |
| Organon Llc | $15.27 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136193604 | CMS |
| Organon Llc | $1.08 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136193606 | CMS |
| PFIZER INC. | $13.15 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132000003 | CMS |
| Sage Therapeutics, Inc. | $36.83 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120404718 | CMS |
| Sage Therapeutics, Inc. | $33.20 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120392211 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.